206. Fragile X syndrome
98 clinical trials,   73 drugs   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways

Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01325740
(ClinicalTrials.gov)
May 201128/3/2011A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X SyndromeA Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of STX107 in Adults With Fragile X SyndromeFragile X SyndromeDrug: STX107Seaside Therapeutics, Inc.NULLSuspended18 Years50 YearsMale16Phase 2United States
2NCT00965432
(ClinicalTrials.gov)
September 200924/8/2009A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy, Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107Fragile X SyndromeDrug: STX107Seaside Therapeutics, Inc.National Institutes of Health (NIH)Completed18 Years50 YearsMale40Phase 1United States